학술논문

Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non-Small Cell Lung Cancer.
Document Type
Article
Source
Science Translational Medicine; 2/6/2013, Vol. 5 Issue 171, p1-11, 11p
Subject
Language
ISSN
19466234